Track the LifeStance Health Group, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, LifeStance Health Group, Inc. has published 183 insider filings. Market capitalisation: €4.7bn. The latest transaction was filed on 4 September 2026 (Cession). Among the most active insiders: Mullins Kevin Michael. Every trade is openly available.
183
Insider Decl.
n/a
Thresholds
€171,276
1 ops.
Buy Volume
€548m
89 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate LifeStance Health Group, Inc. Buy (bullish), based on 10 analysts. Average price target: US$13.80.
44Σ signal
Buys €171,276€548m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,847 of 29,063 companies
37.1
score / 100
Value
43
Quality
32
FCF yld2.3%
Earn yld0.2%
EV/EBITDA·
ROE3.4%
Gross mgn32%
Net mgn0.7%
Debt/EBITDA6.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.